Asian Spectator


The Times

.

CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy

  • Written by PR Newswire Asia - Asian Spectator
CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA NephropathyCSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy

European Commission converts conditional approval of FILSPARI (sparsentan) into standard marketing authorization for the treatment of IgA Nephropathy (IgAN)

Decision follows positive recommendation from Committee for Medicinal Products for Human Use (CHMP) from February 2025

EU approval is based on the complete data set from the phase-III...

Magazine

Compressed Air Pipe and Fittings: What Every Australian Industrial Facility Needs to Know

Compressed air is the fourth utility of modern industry, right alongside electricity, gas, and water. Yet despite its critical role in powering everything from pneumatic tools to automated productio...

Common Risks Hidden in Commercial Lease Agreements

Commercial leases are often longer and more complex than tenants expect, and the fine print can carry significant financial and operational consequences over the years that follow. Many business own...

Corporate Secretarial Services in Singapore: Annual Compliance, Key Filings, and Common Mistake

Annual compliance in Singapore should not be treated as a once-a-year administrative event. It is an ongoing governance system that depends on accurate records, timely filings, disciplined approvals...

hacklink hack forum hacklink film izle hacklink z-librarytelegram下载betwoonzlibrary.jojobetสล็อตสล็อตgrandpashabetstakejojobetTotalSportStreamEasthitbet girişroyalbet girişjojobetjojobetdamabetPadişahbetvipparkmobiladres.comDizipalStreamEastPadişahbetGalabetmostbetvdcasinojojobetcasibomjojobet